Keyphrases
2-dimensional Echocardiography
15%
Accuracy Analysis
30%
Acute Coronary Syndrome
30%
Acute Myocardial Infarction
30%
Arrhythmias Cardiac
13%
Arrhythmogenic Right Ventricular Cardiomyopathy
30%
Atrial Fibrillation
34%
Cardiac Deformation
15%
Cardiac Magnetic Resonance
30%
Cardiac Time Intervals
30%
Coronavirus Disease (COVID)
30%
Corticosteroids
15%
COVID-19
23%
Days Alive without Life Support
15%
Early Diastolic Strain Rate
30%
Echocardiographic
100%
Ejection Fraction
12%
Ejection Time
26%
Global Work
15%
Heart Failure
30%
Hydrocortisone
23%
Incident Heart Failure
30%
Inflow Velocity
30%
Late Gadolinium Enhancement
30%
Left Atrial
33%
Left Atrial Fibrosis
30%
Left Atrial Volume
32%
Low-dose Hydrocortisone
30%
Myocardial Performance Index
48%
Number of Days
15%
Patients at Risk
13%
Patients with COVID-19
30%
Placebo
15%
Quantification Software
30%
Randomized Placebo-controlled Trial
30%
Right Ventricular Function
30%
Severe Hypoxia
30%
Speckle Tracking
18%
Spectral Doppler
15%
Strain Echocardiography
30%
Strain Imaging
30%
Strain Measure
20%
Sudden Cardiac Death
27%
Time-to-event
30%
Transmitral Inflow
30%
Valvular
30%
Ventricular Arrhythmia
53%
Visual Assessment
19%
Volume Quantification
30%
Work Index
15%
Medicine and Dentistry
Acute Heart Infarction
30%
Adverse Event
5%
Aortic Valve
6%
Arrhythmogenic Right Ventricular Dysplasia
30%
Artificial Respiration
5%
Atrial Fibrillation
36%
Cardiac Dysrhythmia
6%
Cardiac Magnetic Resonance Imaging
33%
Cardiomyopathy
10%
Cell Adhesion
7%
Clinical Trial
10%
COVID-19
30%
Diagnosis
7%
Disease
7%
Disease Exacerbation
7%
Echocardiography
54%
Ejection Fraction
12%
Fibrosis
30%
Four Dimensional Echocardiography
12%
Gadolinium
30%
Heart Left Ventricle Ejection Fraction
12%
Heart Left Ventricle Filling Pressure
5%
Heart Right Ventricle Function
7%
Heart Ventricle Arrhythmia
53%
Heart Work
30%
Hydrocortisone
30%
Hypoxia
30%
Implantable Automatic Defibrillator
12%
Incentive
6%
Low Drug Dose
30%
Mean Arterial Pressure
6%
Multimodality Imaging
5%
Myocardium
7%
New-Onset Atrial Fibrillation
5%
Odds Ratio
8%
Placebo
30%
Population Research
6%
Prospective Cohort Study
5%
Randomized Clinical Trial
5%
Reproducibility
30%
Right Ventricular Function
30%
Risk Stratification
7%
Sclerosis
6%
Speckle Tracking Echocardiography
6%
ST Segment Elevation Myocardial Infarction
15%
Strain Imaging
30%
Sudden Cardiac Death
27%
Systolic Dysfunction
6%
Systolic Function
20%
Tissue Doppler Imaging
24%
